Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Animal Generic Drug User Fee Cover Sheet, 43751 [2014-17712]

Download as PDF 43751 Federal Register / Vol. 79, No. 144 / Monday, July 28, 2014 / Notices ANNUAL BURDEN ESTIMATES Number of respondents Instrument Head Start Program Information Report .......................................................... Grantee Monthly Enrollment Reporting ........................................................... Contacts, Locations & Reportable Conditions ................................................. Estimated Total Annual Burden Hours: 13,988.05. Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 370 L’Enfant Promenade SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: infocollection@acf.hhs.gov. OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202–395–7285, Email: OIRA_SUBMISSION@OMB.EOP. GOV, Attn: Desk Officer for the Administration for Children and Families. 3,041 1,773 3,041 Average burden hours per response 1 12 1 Total burden hours 4 0.05 0.25 12,164 1,063.8 760.25 approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. SUPPLEMENTARY INFORMATION: On April 8, 2014, the Agency submitted a proposed collection of information entitled ‘‘Medical Devices; Reports of Corrections and Removals’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0359. The approval expires on July 31, 2017. A copy of the supporting statement for this information collection is available on the Internet at https:// www.reginfo.gov/public/do/PRAMain. FOR FURTHER INFORMATION CONTACT: Dated: July 22, 2014. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2014–17712 Filed 7–25–14; 8:45 am] [FR Doc. 2014–17633 Filed 7–25–14; 8:45 am] Robert Sargis, Reports Clearance Officer. Number of responses per respondent BILLING CODE 4164–01–P FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. SUPPLEMENTARY INFORMATION: On April 28, 2014, the Agency submitted a proposed collection of information entitled ‘‘Animal Generic Drug User Fee Cover Sheet’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0632. The approval expires on July 31, 2017. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. Dated: July 23, 2014. Leslie Kux, Assistant Commissioner for Policy. BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2014–17654 Filed 7–25–14; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Food and Drug Administration Exploring the Possibility of Proprietary Name Reservation for Drug Products; Establishment of a Public Docket Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Animal Generic Drug User Fee Cover Sheet BILLING CODE 4184–01–P [Docket No. FDA–2014–N–0079] [Docket No. FDA–2013–N–0723] mstockstill on DSK4VPTVN1PROD with NOTICES Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Medical Devices; Reports of Corrections and Removals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Medical Devices; Reports of Corrections and Removals’’ has been SUMMARY: VerDate Mar<15>2010 17:53 Jul 25, 2014 Jkt 232001 AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Animal Generic Drug User Fee Cover Sheet’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 [Docket No. FDA–2014–N–1008] AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA or Agency) is establishing a public docket to discuss issues related to reserving proprietary names for drug products. During the negotiations for the 2007 reauthorization of the Prescription Drug User Fee Amendments Act (PDUFA IV), FDA agreed to several performance goals related to the review of drug and biological product proprietary names to reduce medication error. Among those goals, FDA and industry expressed an SUMMARY: E:\FR\FM\28JYN1.SGM 28JYN1

Agencies

[Federal Register Volume 79, Number 144 (Monday, July 28, 2014)]
[Notices]
[Page 43751]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17712]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-0079]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Animal Generic Drug User Fee Cover 
Sheet

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Animal Generic Drug User Fee Cover 
Sheet'' has been approved by the Office of Management and Budget (OMB) 
under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On April 28, 2014, the Agency submitted a 
proposed collection of information entitled ``Animal Generic Drug User 
Fee Cover Sheet'' to OMB for review and clearance under 44 U.S.C. 3507. 
An Agency may not conduct or sponsor, and a person is not required to 
respond to, a collection of information unless it displays a currently 
valid OMB control number. OMB has now approved the information 
collection and has assigned OMB control number 0910-0632. The approval 
expires on July 31, 2017. A copy of the supporting statement for this 
information collection is available on the Internet at https://www.reginfo.gov/public/do/PRAMain.

    Dated: July 23, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-17712 Filed 7-25-14; 8:45 am]
BILLING CODE 4164-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.